Compare DCO & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCO | ALMR |
|---|---|---|
| Founded | 1849 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1995 | 2026 |
| Metric | DCO | ALMR |
|---|---|---|
| Price | $163.08 | $23.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $153.60 | N/A |
| AVG Volume (30 Days) | 199.7K | ★ 242.2K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $824,730,000.00 | N/A |
| Revenue This Year | $7.40 | N/A |
| Revenue Next Year | $8.59 | N/A |
| P/E Ratio | $253.53 | ★ N/A |
| Revenue Growth | ★ 4.85 | N/A |
| 52 Week Low | $80.69 | $21.58 |
| 52 Week High | $168.74 | $23.23 |
| Indicator | DCO | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | N/A |
| Support Level | $135.11 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 6.04 | 0.00 |
| MACD | 0.50 | 0.00 |
| Stochastic Oscillator | 75.38 | 0.00 |
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.